Sleep Cycle AB (publ) (STO:SLEEP)
Sweden flag Sweden · Delayed Price · Currency is SEK
24.55
+0.10 (0.41%)
May 26, 2026, 5:29 PM CET

Sleep Cycle AB Earnings Call Transcripts

Fiscal Year 2026

Fiscal Year 2025

  • Net sales declined amid a soft consumer market, but profitability and cash flow remained strong. Rapid B2B growth and MedTech initiatives are driving a strategic transformation, with 2026 set as an investment year and growth expected to resume in 2027.

  • Q3 saw revenue decline and subscriber softness, but partnership revenue surged 55% year-over-year, now 11% of total revenue. Price increases and product innovation aim to offset headwinds, while the Powered by Sleep SDK and sleep apnea screening initiative drive future growth.

  • Q2 2025 saw a slight decline in subscribers and net sales due to softer D2C market conditions, but partnership revenue grew over 60% year-over-year and now represents nearly 10% of total revenue. Profitability remains strong, and the company is advancing its sleep apnea screening project.

  • Net revenue grew 2.3% year-over-year to SEK 64.9 million, with subscriber base up 1.2% but down sequentially. EBIT margin remained strong at 26.3% despite higher marketing costs, and market share increased amid industry headwinds.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Powered by